Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.36
(-5.33%)
HKD 0.36
(-5.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 72 Thousand CNY | -81.68% |
| 2022 | 393 Thousand CNY | -4.15% |
| 2021 | 410 Thousand CNY | -92.6% |
| 2020 | 5.53 Million CNY | 10.76% |
| 2019 | 5 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 456 Thousand CNY | 0.44% |
| 2024 Q1 | 456 Thousand CNY | 533.33% |
| 2023 Q1 | - CNY | -100.0% |
| 2023 FY | 72 Thousand CNY | -81.68% |
| 2023 Q4 | 72 Thousand CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 Q2 | 134 Thousand CNY | 0.0% |
| 2022 Q1 | 71 Thousand CNY | -82.68% |
| 2022 Q4 | 393 Thousand CNY | 0.0% |
| 2022 FY | 393 Thousand CNY | -4.15% |
| 2022 Q2 | 168 Thousand CNY | 136.62% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 Q4 | 410 Thousand CNY | 494.2% |
| 2021 Q3 | 69 Thousand CNY | -81.45% |
| 2021 Q2 | 372 Thousand CNY | 1182.76% |
| 2021 FY | 410 Thousand CNY | -92.6% |
| 2021 Q1 | 29 Thousand CNY | -99.48% |
| 2020 Q4 | 5.53 Million CNY | -2.69% |
| 2020 FY | 5.53 Million CNY | 10.76% |
| 2020 Q3 | 5.69 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 5 Million CNY | 0.0% |
| 2019 FY | 5 Million CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 778.3 Million HKD | 99.991% |